About Vice-Principal ResearchNews
Glaucoma monitoring device receives CIHR commercialization funding
Date Published: Apr 28, 2025
Contact lens-based device from Queen’s startup LenSense aims to transform glaucoma management and improve patient outcomes.
Cntrl+ Inc. receives clearance from the US Food and Drug Administration
Date Published: Apr 03, 2025
After an arduous journey, Cornwall-based Cntrl+ Inc. officially received clearance from the United States Food and Drug Administration (US FDA) for its reusable female bladder support in December 2024.
March 11, 2025: U.S. Patent No. 12,245,816 "Intraocular Pressure Monitoring Contact Lens"
Date Published: Mar 11, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,245,816
March 11, 2025: U.S. Patent No. 12,245,817 "Non-Invasive Intraocular Pressure Monitor"
Date Published: Mar 11, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,245,816
March 4, 2025: U.S. Patent No. 12,239,639 "Cytotoxic Actin-Targeting Compounds"
Date Published: Mar 04, 2025
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,239,639